During the past decade, University of Illinois, Eye and Ear Infirmary conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Illinois, Eye and Ear Infirmary" #1 sponsor was "Jaeb Center for Health Research" with 2 trials, followed by "National Eye Institute (NEI)" with 2 trials sponsored, "OccuLogix" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Hermann Eye Center" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Illinois, Eye and Ear Infirmary" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator, "Alcon Research" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University of Illinois, Eye and Ear Infirmary" are "Retinopathy of Prematurity" (3 trials), "Macular Degeneration" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Dry Eye" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "University of Illinois, Eye and Ear Infirmary" in a lesser frequency.

Most popular intervention types in "University of Illinois, Eye and Ear Infirmary" are "Drug" (5 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Rheopheresis blood filtration" (2 trials), "Alphagan P" (1 trials), "Argon Laser Trabeculoplasty" (1 trials) and "Azopt" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Illinois, Eye and Ear Infirmary" are 9 trials for "All" genders.

Currently, there are NaN active trials in "University of Illinois, Eye and Ear Infirmary". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Illinois, Eye and Ear Infirmary, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Illinois, Eye and Ear Infirmary, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".